News Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ com... Brent Saunders has been out of the limelight for a few months since departing Allerg
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News Petition to block Trump state visit to UK grows to 1.6 milli... Biotech leaders speak out, but pharma largely silent
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
